Susquehanna International Group, LLP Merrimack Pharmaceuticals Inc Put Options Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

Put Options

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held	SEC Form
Q4 2023 Feb 14, 2024	BUY	$12.02 - $13.41 $189,916 - $211,878	15,800 Added 13.5%	132,800 $1.78 Million
Q3 2023 Nov 14, 2023	BUY	$11.6 - $12.52 $1.04 Million - $1.13 Million	89,900 Added 331.73%	117,000 $1.44 Million
Q2 2023 Aug 11, 2023	SELL	$12.02 - $13.07 $2.07 Million - $2.25 Million	-172,300 Reduced 86.41%	27,100 $333,000
Q1 2023 May 16, 2023	BUY	$11.35 - $12.32 $135,065 - $146,608	11,900 Added 6.35%	199,400 $2.45 Million
Q4 2022 Feb 14, 2023	BUY	$3.68 - $12.51 $648,784 - $2.21 Million	176,300 Added 1574.11%	187,500 $2.15 Million
Q3 2022 Nov 14, 2022	SELL	$3.7 - $6.06 $62,900 - $103,020	-17,000 Reduced 60.28%	11,200 $42,000

Others Institutions Holding MACK

# of Institutions

2

Shares Held

349

Call Options Held

0

Put Options Held

0

About MERRIMACK PHARMACEUTICALS INC

Ticker MACK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 13,410,200
Market Cap $203M
Description
Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.

More about MACK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.